ストックスクリーナーアプリを入手
5.42
10.61%
0.52
Avalon Globocare Corp (ALBT) 最新ニュース
Avalon GloboCare (NASDAQ: ALBT) Receives Notice of Allowance for Innovative CAR-T and CAR-NK Cell Technology in ChinaFREEHOLD, N.J., February 18, 2025 – Avalon GloboCare Corp. (NASDAQ: ALBT), a leading developer of precision diagnostics a - Defense World
Avalon GloboCare Receives Notice of Allowance for Groundbreaking CAR-T and CAR-NK Cell Technology in China - GlobeNewswire
Avalon GloboCare Receives Notice of Allowance for Chimeric Antigen Receptor Cell Technology in China - Marketscreener.com
Avalon GloboCare Secures Patent for CAR-T Technology - TipRanks
Avalon GloboCare secures patent in China for CAR therapy tech - Investing.com
Avalon GloboCare secures patent in China for CAR therapy tech By Investing.com - Investing.com Canada
Revolutionary Cancer Treatment Patent: Avalon's Dual-Target CAR-T Therapy Gets China's Green Light - StockTitan
Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update - Defense World
Head to Head Analysis: Sangamo Therapeutics (NASDAQ:SGMO) versus Avalon GloboCare (NASDAQ:ALBT) - Defense World
Avalon GloboCare announces preferred stock exchange and amendment By Investing.com - Investing.com Australia
Avalon GloboCare announces preferred stock exchange and amendment - Investing.com India
Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific and Clinical Advisory Board - Marketscreener.com
Avalon GloboCare Corp. (NASDAQ:ALBT) Sees Significant Increase in Short Interest - Defense World
Avalon GloboCare Enters into Securities Purchase Agreement with InvestorOn December 19, 2024, Avalon GloboCare Corp. (NASDAQ: ALBT) announced that it had entered into a securities purchase agreement with an accredited investor, York Sun Investme - Defense World
Avalon GloboCare announces $7M preferred stock sale By Investing.com - Investing.com Nigeria
Avalon GloboCare announces $7M preferred stock sale - Investing.com India
Avalon GloboCare (NASDAQ:ALBT) vs. Krystal Biotech (NASDAQ:KRYS) Head-To-Head Analysis - Defense World
3 Penny Stocks to Watch Now, 12/10/24 - TipRanks
Why Interpublic Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Avalon GloboCare Regains Nasdaq Compliance - Investing.com
Avalon GloboCare Achieves Nasdaq Compliance with Strong Governance - TipRanks
Avalon GloboCare Regains Compliance with Nasdaq Continued Listing Requirements - GlobeNewswire
Avalon GloboCare Regains Nasdaq Compliance, Reaffirms Growth Strategy | ALBT Stock News - StockTitan
Avalon launches ‘BrAce for Impact’ affiliate marketing program - TipRanks
Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device - GlobeNewswire
Avalon GloboCare Launches AI-Powered KetoAir™ Affiliate Program for Ketosis Monitoring | ALBT Stock News - StockTitan
Critical Review: Innate Pharma (NASDAQ:IPHA) vs. Avalon GloboCare (NASDAQ:ALBT) - Defense World
Avalon GloboCare Third Quarter 2024 Earnings: US$1.82 loss per share (vs US$2.06 loss in 3Q 2023) - Yahoo Finance
Avalon GloboCare Corp. (ALBT) Quarterly 10-Q Report - Quartz
U.S. Stock market: Zoomcar Holdings (+192.21%), Avalon GloboCare (+56.73%), and Vimeo (+40.85%) experience significant gains during mid day trading - Business Upturn
U.S. Stock market: Zoomcar Holdings up 87.10%, Avalon GloboCare jumps 57.14%, Vimeo rises 44.07% among top gainers - Business Upturn
U.S. Stock market: Verrica Pharmaceuticals and Marqeta stocks plummet over 37%, while Avalon GloboCare soars 75% in volatile market trend - Business Upturn
Avalon Globocare stock hits 52-week low at $2.4 amid market challenges - Investing.com Canada
Avalon Globocare stock hits 52-week low at $2.4 amid market challenges By Investing.com - Investing.com South Africa
Avalon GloboCare faces Nasdaq delisting after rule breach - Investing.com India
Avalon GloboCare Appoints Dr. Charles Cavo to Scientific Advisory Board Support for KetoAir Sales - Defense World
Avalon GloboCare faces Nasdaq delisting after rule breach By Investing.com - Investing.com South Africa
Avalon appoints Cavto to Scientific Advisory Board - TipRanks
Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales - GlobeNewswire
Avalon GloboCare Announces Reverse Stock Split and Decrease in Shares By Investing.com - Investing.com South Africa
Avalon GloboCare Announces Reverse Stock Split and Decrease in Shares - Investing.com
Avalon Globocare stock hits 52-week high at $3.45 By Investing.com - Investing.com South Africa
Avalon Globocare stock hits 52-week high at $3.45 - Investing.com
4.90%
大文字化:
|
ボリューム (24 時間):